Funder Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Department of Defense  

$7,082,059.00
Fiscal Year: 2010

Download 2010 Department of Defense projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Excessive cap-dependent translation as a molecular mechanism underlying ASD Klann, Eric Q2.Other New York University
Analysis of the small intestinal microbiome of children with autism Kushak, Rafail Q3.S.I Massachusetts General Hospital
Modulation of fxr1 splicing as a treatment strategy for autism in fragile X syndrome Lin, Michael Q2.S.D Stanford University
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders - 1 Lipton, Stuart Q4.S.B Burnham Institute
Neural correlates of restricted, repetitive behaviors in autism spectrum disorders Manoach, Dara Q2.S.G Massachusetts General Hospital
Epigenetic regulation of the autism susceptibility gene, ENGRAILED 2 (EN2) Millonig, James Q3.S.J University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School
A randomized clinical trial of cognitive enhancement therapy for adults with autism spectrum disorders Minshew, Nancy Q4.S.F University of Pittsburgh
Etiology of sleep disorders in ASD: Role of inflammatory cytokines Mong, Jessica Q2.S.E University of Maryland, Baltimore
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Moy, Sheryl Q4.S.B University of North Carolina at Chapel Hill
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders -2 Nakanishi, Nobuki Q4.S.B Burnham Institute
Redox abnormalities as a vulnerability phenotype for autism and related alterations in CNS development Noble, Mark Q2.S.A University of Rochester
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial Novotny, Sherie Q4.L.A University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School
Novel probiotic therapies for autism Patterson, Paul Q4.S.B California Institute of Technology
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Pedersen, Cort Q4.S.B University of North Carolina at Chapel Hill
Improving synchronization and functional connectivity in autism spectrum disorders through plasticity-induced rehabilitation training Pineda, Jaime Q4.S.F University of California, San Diego
Neural basis of empathy and its dysfunction in autism spectrum disorders (ASD) Platt, Michael Q2.Other Duke University
Serotonin signal transduction in two groups of autistic patients Rasenick, Mark Q2.Other University of Illinois at Chicago
Novel strategies to manipulate Ube3a expression for the treatment of autism and Angelman syndrome Roth, Bryan Q4.S.B University of North Carolina at Chapel Hill
Placental vascular tree as biomarker of autism/ASD risk Salafia, Carolyn Q1.L.A Research Foundation for Mental Hygiene, Inc.
The transcription factor PLZF: A possible genetic link between immune dysfunction and autism Sant'Angelo, Derek Q3.L.B Memorial Sloan-Kettering Cancer Center
Neural correlates of restricted, repetitive behaviors in autism spectrum disorders Santangelo, Susan Q2.S.G Massachusetts General Hospital
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Santangelo, Susan Q3.L.C Massachusetts General Hospital
Mechanisms of mitochondrial dysfunction in autism Shoffner, John Q2.S.A Georgia State University
Developing treatment, treatment validation, and treatment scope in the setting of an autism clinical trial Stein, Peter Q4.L.A University of Medicine & Dentistry of New Jersey
Family studies of sensorimotor and neurocognitive heterogeneity in autism spectrum disorders (ASD) Sweeney, John Q1.L.B University of Texas Southwestern Medical Center at Dallas